Incidence, risk factors and outcomes of seizures occurring after craniotomy for primary brain tumor resection

References

1. ↵
   1. Porter KR,
   2. McCarthy BJ,
   3. Freels S,
   4. Kim Y,
   5. Davis FG

   (2010) Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology. Neuro Oncol 12, 520–527.
2. ↵
   1. Glantz MJ,
   2. Cole BF,
   3. Forsyth PA,
   4. Recht LD,
   5. Wen PY,
   6. Chamberlain MC,
   7. et al.

   (2000) Practice parameter:anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54, 1886–1893.
3. ↵
   1. Lynam LM,
   2. Lyons MK,
   3. Drazkowski JF,
   4. Sirven JI,
   5. Noe KH,
   6. Zimmerman RS,
   7. et al.

   (2007) Frequency of seizures in patients with newly diagnosed brain tumors:a retrospective review. Clin Neurol Neurosurg 109, 634–638.
4. ↵
   1. Lee JW,
   2. Wen PY,
   3. Hurwitz S,
   4. Black P,
   5. Kesari S,
   6. Drappatz J,
   7. et al.

   (2010) Morphological characteristics of brain tumors causing seizures. Arch Neurol 67, 336–342.
5. ↵
   1. Boarini DJ,
   2. Beck DW,
   3. VanGilder JC

   (1985) Postoperative prophylactic anticonvulsant therapy in cerebral gliomas. Neurosurgery 16, 290–292.
6. ↵
   1. Telfeian AE,
   2. Philips MF,
   3. Crino PB,
   4. Judy KD

   (2001) Postoperative epilepsy in patients undergoing craniotomy for glioblastoma multiforme. J Exp Clin Cancer Res 20, 5–10.
7. ↵
   1. Sughrue ME,
   2. Rutkowski MJ,
   3. Chang EF,
   4. Shangari G,
   5. Kane AJ,
   6. McDermott MW,
   7. et al.

   (2011) Postoperative seizures following the resection of convexity meningiomas:are prophylactic anticonvulsants indicated? Clinical article J Neurosurg 114, 705–709.
8. ↵
   1. Wu AS,
   2. Trinh VT,
   3. Suki D,
   4. Graham S,
   5. Forman A,
   6. Weinberg JS,
   7. et al.

   (2013) A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors. J Neurosurg 118, 873–883.
9. ↵
   1. Van Breemen MS,
   2. Wilms EB,
   3. Vecht CJ

   (2007) Epilepsy in patients with brain tumours:epidemiology, mechanisms, and management. Lancet Neurol 6, 421–430.
10. ↵
    1. Englot DJ,
    2. Magill ST,
    3. Han SJ,
    4. Chang EF,
    5. Berger MS,
    6. McDermott MW

    (2016) Seizures in supratentorial meningioma:a systematic review and meta-analysis. J Neurosurg 124, 1552–1561.
11. ↵
    1. Komotar RJ,
    2. Raper DM,
    3. Starke RM,
    4. Iorgulescu JB,
    5. Gutin PH

    (2011) Prophylactic antiepileptic drug therapy in patients undergoing supratentorial meningioma resection:a systematic analysis of efficacy. J Neurosurg 115, 483–490.
12. ↵
    1. Siomin V,
    2. Angelov L,
    3. Li L,
    4. Vogelbaum MA

    (2005) Results of a survey of neurosurgical practice patterns regarding the prophylactic use of anti-epilepsy drugs in patients with brain tumors. J Neurooncol 74, 211–215.
13. ↵
    1. Arabi Y,
    2. Alshimemeri A,
    3. Taher S

    (2006) Weekend and weeknight admissions have the same outcome of weekday admissions to an intensive care unit with onsite intensivist coverage. Crit Care Med 34, 605–611.
14. ↵
    1. Knaus WA,
    2. Draper EA,
    3. Wagner DP,
    4. Zimmerman JE

    (1985) AAPACHE II:a severity of disease classification system. Crit Care Med 13, 818–829.
15. ↵
    1. Lee JW,
    2. Wen PY,
    3. Hurwitz S,
    4. Black P,
    5. Kesari S,
    6. Drappatz J,
    7. et al.

    (2010) Morphological characteristics of brain tumors causing seizures. Arch Neurol 67, 336–342.
16. ↵
    1. Wirsching HG,
    2. Morel C,
    3. Gmür C,
    4. Neidert MC,
    5. Baumann CR,
    6. Valavanis A,
    7. et al.

    (2016) Predicting outcome of epilepsy after meningioma resection. Neuro Oncol 18, 1002–1010.
17. ↵
    1. Hamed SA

    (2007) Leptin and insulin homeostasis in epilepsy:relation to weight adverse conditions. Epilepsy Res 75, 1–9.
18. ↵
    1. Telfeian AE,
    2. Philips MF,
    3. Crino PB,
    4. Judy KD

    (2001) Postoperative epilepsy in patients undergoing craniotomy for glioblastoma multiforme. J Exp Clin Cancer Res 20, 5–10.
19. ↵
    1. Pruitt AA

    (2011) Medical management of patients with brain tumors. Curr Treat Options Neurol 13, 413–426.
20. ↵
    1. Sirven JI,
    2. Wingerchuk DM,
    3. Drazkowski JF,
    4. Lyons MK,
    5. Zimmerman RS

    (2004) Seizure prophylaxis in patients with brain tumors:a meta-analysis. Mayo Clin Proc 79, 1489–1494.
21. ↵
    1. Tremont-Lukats IW,
    2. Ratilal BO,
    3. Armstrong T,
    4. Gilbert MR

    (2008) Antiepileptic drugs for preventing seizures in people with brain tumors. Cochrane Database Syst Rev 2, CD004424.
22. ↵
    1. Lockney DT,
    2. Vaziri S,
    3. Walch F,
    4. Kubilis P,
    5. Neal D,
    6. Murad GJ,
    7. et al.

    (2017) Prophylactic Antiepileptic Drug Use in Patients with Brain Tumors Undergoing Craniotomy. World Neurosurg 98, 28–33.
23. ↵
    1. Pulman J,
    2. Greenhalgh J,
    3. Marson AG

    (2013) Antiepileptic drugs as prophylaxis for post-craniotomy seizures. Cochrane Database Syst Rev 2, CD007286.
24. ↵
    1. Koubeissi M

    (2014) Do we need seizure prophylaxis for brain tumor surgery? Epilepsy Curr 14, 24–25.
25. ↵
    1. Gokhale S,
    2. Khan SA,
    3. Agrawal A,
    4. Friedman AH,
    5. McDonagh DL

    (2013) Levetiracetam seizure prophylaxis in craniotomy patients at high risk for postoperative seizures. Asian J Neurosurg 8, 169–173.
26. ↵
    1. Iuchi T,
    2. Kuwabara K,
    3. Matsumoto M,
    4. Kawasaki K,
    5. Hasegawa Y,
    6. Sakaida T

    (2015) Levetiracetam versus phenytoin for seizure prophylaxis during and early after craniotomy for brain tumours:a phase II prospective, randomised study. J Neurol Neurosurg Psychiatry 86, 1158–1162.
27. ↵
    1. Dube SK,
    2. Rath GP,
    3. Bharti SJ,
    4. Bindra A,
    5. Vanamoorthy P,
    6. Gupta N,
    7. et al.

    (2013) Causes of tracheal re-intubation after craniotomy:A prospective study. Saudi J Anaesth 7, 410–414.